Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,158 | -35,910 | -24,075 | -13,337 | -40,571 |
| Depreciation Amortization | 1,391 | 1,083 | 441 | 169 | 431 |
| Income taxes - deferred | 219 | 45 | 38 | 16 | 693 |
| Accounts payable and accrued liabilities | 1,727 | 1,221 | 1,327 | 2,208 | -1,146 |
| Other Working Capital | -1,425 | -1,972 | -3,221 | -2,996 | 5,060 |
| Other Operating Activity | 6,419 | 4,375 | 2,414 | -376 | 5,724 |
| Operating Cash Flow | $-41,827 | $-31,158 | $-23,076 | $-14,316 | $-29,809 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -119,356 | -113,135 | -117,652 | -96,792 | 7,277 |
| PPE Investments | -340 | -140 | -66 | -24 | -584 |
| Investing Cash Flow | $-119,696 | $-113,275 | $-117,718 | $-96,816 | $6,693 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 16,876 |
| Debt Issued | 149,080 | 149,080 | 149,080 | 149,080 | N/A |
| Debt Repayment | -12,880 | -12,880 | -12,880 | -12,880 | N/A |
| Common Stock Issued | 914 | 898 | 101 | N/A | 120 |
| Other Financing Activity | -2,721 | -2,721 | -2,721 | -1,031 | 68,519 |
| Financing Cash Flow | $134,393 | $134,377 | $133,580 | $135,169 | $85,515 |
| Exchange Rate Effect | -25 | -47 | -51 | -62 | 80 |
| Beginning Cash Position | 74,854 | 74,854 | 74,854 | 74,854 | 12,375 |
| End Cash Position | 47,699 | 64,751 | 67,589 | 98,829 | 74,854 |
| Net Cash Flow | $-27,155 | $-10,103 | $-7,265 | $23,975 | $62,479 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,827 | -31,158 | -23,076 | -14,316 | -29,809 |
| Capital Expenditure | -340 | -140 | -66 | -24 | -584 |
| Free Cash Flow | -42,167 | -31,298 | -23,142 | -14,340 | -30,393 |